Advancements across Health and Wellness

USD 250

* Required Fields

USD 250


Be the first to review this product

Innovations across health and wellness are improving the quality of diagnosis and prevention. Currently, preventative solutions are gaining a wider acceptance, while solutions like probiotics that supplement the nutrition needs of an individual are important for ensuring a healthy population. However, the current state of diagnosis needs to ensure that physicians get results from blood tests and simple diagnostic tests quicker. Steady steps are being taken to develop point of care diagnostics that will yield the results that most physicians require. These technologies can be stationed in all clinics, hospitals, and even remote villages with limited infrastructure for large scale diagnostics equipment.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Probiotics, nutrition, sepsis, biomarkers, sepsis diagnosis, gut health, oral health, oral cavity

Table of Contents

Advancements across Health and WellnessTechnological Innovation ProfilesImmunized Egg Powder Becomes a Suitable Prebiotic Ingredient to Be Included in Supplements Probiotic Products Aid in Reducing Microflora within Oral Cavities Leading Probiotic Raw and Functional Ingredients in Southeast AsiaTECHNOLOGY CAPABILITY – UNIQUE FEATURESOral Cancer Therapeutics – Active Clinical TrialsIndustry Contacts




Related Research

Release Date : 31-Oct-17

Region : Global

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Related Subscription

• One-2-One Analyst briefing call •
• Access to published and new research deliverables •
• Mid year service review •
• Virtual Analyst briefing •
• GIL conference seats •

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.